We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Life Sciences Companies Webcast Live to Online Investors, July 12th, at RetailInvestorConferences.com CEOs to take questions in real-time during formal roadshow presentations, meet and "chat" in...
NYSE Companies' and NASDAQ Companies' June 7th Investor Presentations Now Available at RetailInvestorConferences.com Free educational sessions: focus on biotech and healthcare stocks PR...
Senesco Technologies, Inc. to Webcast, Live, at RetailInvestorConferences.com on June 7th Company invites Main Street and Wall Street investors to attend interactive real-time virtual...
NYSE Companies and NASDAQ Companies Meet to Webcast Live, June 7th, at RetailInvestorConferences.com Free educational sessions: focus on biotech and healthcare stocks PR Newswire NEW YORK, June...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT) reported today on the progress of its Phase 1b/2a study for the treatment of multiple myeloma, which is...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that a poster describing the ongoing SNS01-T study in multiple myeloma will be presented...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE MKT: SNT), announced today that the characteristics and activity of SNS01 have been released on-line in Molecular...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT) today reported financial results for the third quarter of fiscal year 2012 which ended on March 31...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE Amex: SNT), announced today that an oral presentation will be delivered at the 15th Annual Meeting of the American...
Senesco Technologies, Inc. (“Senesco” or the “Company”) (NYSE AMEX: SNT) announced today that a high level of tumor eradication in a mouse model of human multiple myeloma was...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions